Christophe Piketty, MD, PhD

home / authors / christophe-piketty-md-phd

Articles

Christophe Piketty, MD, PhD: The Role of Nemolizumab in Addressing Unmet Needs of Patients With AD and PN

Christophe Piketty, MD, PhD: The Role of Nemolizumab in Addressing Unmet Needs of Patients With AD and PN

Emma Andrus, Editor;Christophe Piketty, MD, PhD
February 27th 2025

Christophe Piketty, MD, PHD, provides a deeper look at the promise of nemolizumab in addressing unmet needs faced by patients with atopic dermatitis and prurigo nodularis.

Christophe Piketty, MD, PhD: Nemolizumab's Unique Mechanism of Action and Next Steps Globally

Christophe Piketty, MD, PhD: Nemolizumab's Unique Mechanism of Action and Next Steps Globally

Emma Andrus, Editor;Christophe Piketty, MD, PhD
February 26th 2025

Christophe Piketty, MD, PHD, discusses the promising efficacy, novel mechanisms, and patient benefits of nemolizumab in targeting IL-31 for atopic dermatitis and prurigo nodularis.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
FDA Approves First Gene Therapy for RDEB
Published: April 29th 2025 | Updated: May 3rd 2025
FDA Approves First Gene Therapy for RDEB
FDA Approves Dupilumab for Adolescents and Adults With H1 Antihistamine-Refractory Chronic Spontaneous Urticaria
Published: April 18th 2025 | Updated: May 3rd 2025
FDA Approves Dupilumab for Adolescents and Adults With H1 Antihistamine-Refractory Chronic Spontaneous Urticaria
Using Real-World AD Cases to Pick the Right Therapy for Each Patient
Published: April 22nd 2025 | Updated: May 3rd 2025
Using Real-World AD Cases to Pick the Right Therapy for Each Patient
Optimizing Vitiligo Care: Key Expert Takeaways
Published: April 1st 2025 | Updated: May 3rd 2025
Optimizing Vitiligo Care: Key Expert Takeaways
POLL: Which Cosmeceuticals Are Most Popular, According to Social Media?
Published: April 10th 2025 | Updated: May 3rd 2025
POLL: Which Cosmeceuticals Are Most Popular, According to Social Media?
© 2025 MJH Life Sciences

All rights reserved.